DMEM, Univ Montpellier, INRAE, Montpellier, France.
CIRAD, UMR Qualisud, 34398 Montpellier, France; Qualisud, Univ Montpellier, Avignon Université, CIRAD, Institut Agro, IRD, Université de La Réunion, Montpellier, France.
Biomed Pharmacother. 2023 Aug;164:114945. doi: 10.1016/j.biopha.2023.114945. Epub 2023 May 30.
The increase in obesity has become a major global health problem and is associated with numerous metabolic dysfunctions. Furan fatty acids (FuFAs) are minor lipids present in our diet. Recently we showed that FuFA-F2 extracted from Hevea brasiliensis latex stimulates muscle anabolism in mice in vitro and in vivo, mimicking in part physical activity. While skeletal muscle is essential for energy metabolism and is the predominant site of insulin-mediated glucose uptake in the post prandial state, our results suggested that FuFA-F2 could have favorable effects against obesity. The aim of this work was therefore to study whether a preventive nutritional supplementation with FuFA-F2 (40 mg or 110 mg/day/kg of body weight) in a diet-induced obesity (DIO) mouse model may have beneficial effects against obesity and liver and skeletal muscle metabolic dysfunction. We showed that 12 weeks of FuFA-F2 supplementation in DIO mice decreased fat mass, increased lean mass and restored normal energy expenditure. In addition, we found that FuFA-F2 improved insulin sensitivity. We revealed that FuFA-F2 increased muscle mass but had no effect on mitochondrial function and oxidative stress in skeletal muscle. Furthermore, we observed that FuFA-F2 supplementation reduced liver steatosis without impact on mitochondrial function and oxidative stress in liver. Our findings demonstrated for the first time that a preventive nutritional supplementation with a furan fatty acid in DIO mice reduced metabolic disorders and was able to mimic partly the positive effects of physical activity. This study highlights that nutritional FuFA-F2 supplementation could be an effective approach to treat obesity and metabolic syndrome.
肥胖的增加已成为一个主要的全球健康问题,与许多代谢功能障碍有关。呋喃脂肪酸(FuFAs)是我们饮食中存在的少量脂质。最近我们表明,从巴西橡胶树乳胶中提取的 FuFA-F2 在体外和体内刺激肌肉合成代谢,部分模拟了体力活动。虽然骨骼肌对于能量代谢至关重要,并且是餐后胰岛素介导的葡萄糖摄取的主要部位,但我们的结果表明,FuFA-F2 可能对肥胖有有利影响。因此,这项工作的目的是研究在饮食诱导肥胖(DIO)小鼠模型中预防性营养补充 FuFA-F2(40mg 或 110mg/天/公斤体重)是否可能对肥胖和肝脏及骨骼肌代谢功能障碍产生有益影响。我们表明,在 DIO 小鼠中补充 12 周的 FuFA-F2 可减少脂肪量,增加瘦体重并恢复正常的能量消耗。此外,我们发现 FuFA-F2 提高了胰岛素敏感性。我们揭示 FuFA-F2 增加了肌肉量,但对骨骼肌的线粒体功能和氧化应激没有影响。此外,我们观察到 FuFA-F2 补充减少了肝脂肪变性,而对肝脏的线粒体功能和氧化应激没有影响。我们的研究结果首次表明,在 DIO 小鼠中预防性营养补充呋喃脂肪酸可减少代谢紊乱,并能部分模拟体力活动的积极影响。这项研究强调了营养 FuFA-F2 补充可能是治疗肥胖和代谢综合征的有效方法。